Dispositions (Details) - USD ($) $ in Millions |
12 Months Ended | |
---|---|---|
Nov. 04, 2015 |
Dec. 31, 2018 |
|
Asset Purchase Agreement And Ology Bioservices License Agreement | ||
Dispositions | ||
Cash consideration | $ 4.6 | |
Amount received from sale of discontinued operation | $ 2.5 | |
Biodefense Business | ||
Dispositions | ||
Royalties receivable percentage on net sales | 15.00% |
X | ||||||||||
- Definition Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount received from sale of discontinued operation recognized as other income during the period. No definition available.
|
X | ||||||||||
- Definition Royalty receivable entity is eligible to receive as a percentage on net sales. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|